DE60215195T2 - Derivate morphinähnlicher opioidverbindungen - Google Patents

Derivate morphinähnlicher opioidverbindungen Download PDF

Info

Publication number
DE60215195T2
DE60215195T2 DE60215195T DE60215195T DE60215195T2 DE 60215195 T2 DE60215195 T2 DE 60215195T2 DE 60215195 T DE60215195 T DE 60215195T DE 60215195 T DE60215195 T DE 60215195T DE 60215195 T2 DE60215195 T2 DE 60215195T2
Authority
DE
Germany
Prior art keywords
compound
formula
substituted
group
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60215195T
Other languages
German (de)
English (en)
Other versions
DE60215195D1 (de
Inventor
Roy William Camberwell JACKSON
Rupika Kamani Glen Waverley SUBASINGHE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monash University
Neuro Therapeutics Ltd
Original Assignee
Monash University
Neuro Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR6938A external-priority patent/AUPR693801A0/en
Priority claimed from AUPR9640A external-priority patent/AUPR964001A0/en
Application filed by Monash University, Neuro Therapeutics Ltd filed Critical Monash University
Publication of DE60215195D1 publication Critical patent/DE60215195D1/de
Application granted granted Critical
Publication of DE60215195T2 publication Critical patent/DE60215195T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DE60215195T 2001-08-10 2002-08-09 Derivate morphinähnlicher opioidverbindungen Expired - Fee Related DE60215195T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPR693801 2001-08-10
AUPR6938A AUPR693801A0 (en) 2001-08-10 2001-08-10 Therapeutic compounds
AUPR964001 2001-12-19
AUPR9640A AUPR964001A0 (en) 2001-12-19 2001-12-19 Therapeutic compounds
PCT/AU2002/001088 WO2003014122A1 (en) 2001-08-10 2002-08-09 Derivatives of morphine-like opioid compounds

Publications (2)

Publication Number Publication Date
DE60215195D1 DE60215195D1 (de) 2006-11-16
DE60215195T2 true DE60215195T2 (de) 2007-08-23

Family

ID=25646773

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60215195T Expired - Fee Related DE60215195T2 (de) 2001-08-10 2002-08-09 Derivate morphinähnlicher opioidverbindungen

Country Status (7)

Country Link
US (1) US7199129B2 (cg-RX-API-DMAC7.html)
EP (1) EP1423392B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005500373A (cg-RX-API-DMAC7.html)
AT (1) ATE341552T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002322169B2 (cg-RX-API-DMAC7.html)
DE (1) DE60215195T2 (cg-RX-API-DMAC7.html)
WO (1) WO2003014122A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040204862A1 (en) * 2003-04-11 2004-10-14 Wainer Irving W. Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors
TWI630208B (zh) 2008-12-08 2018-07-21 歐陸斯迪公司 二氫羥戊甲嗎啡
US9351973B2 (en) 2011-09-22 2016-05-31 Merck Sharp & Dohme Corp. Pyrazolopyridyl compounds as aldosterone synthase inhibitors
WO2013043518A1 (en) 2011-09-22 2013-03-28 Merck Sharp & Dohme Corp. Imidazopyridyl compounds as aldosterone synthase inhibitors
EP2757883B1 (en) 2011-09-22 2021-01-13 Merck Sharp & Dohme Corp. Triazolopyridyl compounds as aldosterone synthase inhibitors
WO2014015157A2 (en) 2012-07-19 2014-01-23 Philadelphia Health & Education Corporation Novel sigma receptor ligands and methods of modulating cellular protein homeostasis using same
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method
US9920836B2 (en) * 2013-10-18 2018-03-20 Kabushiki Kaisha Riken Piston ring for internal combustion engine
US11117870B2 (en) 2017-11-01 2021-09-14 Drexel University Compounds, compositions, and methods for treating diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341538A (en) * 1965-06-18 1967-09-12 Geigy Chem Corp Certain 2, 6-methano-3-benzazocines
WO1999038869A1 (en) 1998-01-29 1999-08-05 Monash University Therapeutic compounds
KR100602929B1 (ko) * 2000-08-31 2006-07-20 에프. 호프만-라 로슈 아게 알파-1 아드레날린성 길항제로서 퀴나졸린 유도체

Also Published As

Publication number Publication date
WO2003014122A1 (en) 2003-02-20
EP1423392A4 (en) 2004-11-17
ATE341552T1 (de) 2006-10-15
US20040242616A1 (en) 2004-12-02
DE60215195D1 (de) 2006-11-16
JP2005500373A (ja) 2005-01-06
US7199129B2 (en) 2007-04-03
EP1423392A1 (en) 2004-06-02
EP1423392B1 (en) 2006-10-04
AU2002322169B2 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
DE60133584T2 (de) 4-arylpiperidine als opioidrezeptorbindende agenzien
DE69929173T2 (de) Therapeutische verbindungen
DE69822514T2 (de) Wasserlösliche pro-pharmaka von arzneistoffen, die ein tertiäres amin enthalten, und verfahren zu ihrer herstellung
DE60312701T2 (de) Darstellung von 1h-imidazoä4,5-cüchinolin-4-aminen über neue 1h-imidazoä4,5-cüchinolin-4-cyano- und 1h-imidazoä4,5-cüchinolin-4-carboxamid intermediate
DE69901379T2 (de) Camptothecin-Derivate mit Antitumor-Wirkung
DE69424853T2 (de) Morphinan-derivate und ihre medizinische verwendung
DE60225673T2 (de) Kappa-opioid-rezeptor-liganden
DE69819891T2 (de) Spiro chinuclidin-derivate, ihre herstellung und verwendung
DE69205287T2 (de) Imidazolylalkyl- piperazin und -diazepin derivate als histamin h3 agonisten/antagonisten.
EP1456212B1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
DE60317684T2 (de) SUBSTITUIERTE 2,4-DIHYDROPYRROLOc3,4BÜCHINOLIN-9-ONDERIVATE, DIE SICH ALS PHOSPHODIESTERASEINHIBITOREN EIGNEN
DE3887544T2 (de) Beta-aminoethyl-substituierte Phenyl-Verbindungen, diese enthaltende entzündungshemmende oder analgetische Zusammensetzungen.
DE60222286T2 (de) Verfahren zur erhöhung des testosteronspiegels
EP1423392B1 (en) Derivatives of morphine-like opioid compounds
DE69530205T2 (de) Heterocyclisch kondensierte morphinoid-derivate
DE69815336T2 (de) Morphin-derivate
DE112010001980T5 (de) Synthese von Morphin und Verwandten Derivaten
DE60308368T3 (de) Camptothecine mit modifiziertem lactonring
AU2002322169A1 (en) Derivatives of morphine-like opioid compounds
EP0900212B1 (de) Chirale phenyldihydrofuranone als pde-iv inhibitoren
DE69230498T2 (de) 2-Pyrazinylethylamin-Derivate und ihre Verwendung als Arzneimittel.
DE10048715A1 (de) Verwendung von Aminosäure zur Behandlung von Schmerz
DE60319989T2 (de) Diazabicyclononan - und decanderivate und ihre verwendung als opioid-rezeptorligande
DE69826881T2 (de) Neue indolcarboxamide, pharmazeutische zusammensetzungen und methoden zur hemmung von calpain
DE2832309C2 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee